Dysproteinemias


A set of diseases known as dysproteinemias are defined by an excessive synthesis of a monoclonal (M) protein as a result of aberrant clonal growth of plasma cells. An immunoglobulin fragment (light chain or heavy chain) or a whole immunoglobulin can both be this M protein. These conditions are collectively referred to as "dysproteinemias," "paraproteinemias," or "monoclonal gammopathies" and include multiple myeloma, light-chain amyloidosis, monoclonal gammopathy of uncertain significance, and others.


    Related Conference of Dysproteinemias

    June 13-14, 2024

    9th World Kidney Congress

    Barcelona, Spain
    July 01-02, 2024

    6th International Conference on Clinical Immunology, Neuropharmacology and Drug Development

    Edinburgh, Scotland
    July 25-26, 2024

    28th European Nephrology Conference

    Frankfurt, Germany
    August 19-20, 2024

    4th International Conference on Kidney Failure & Renal Care

    London, UK
    September 19-20, 2024

    25th Global Nephrology, Urology and Kidney Failure Congress

    Paris, France
    October 03-04, 2024

    22nd International Conference on Nephrology, Urology and Therapeutics

    Singapore City, Singapore
    November 13-14, 2024

    21st International Conference on Nephrology and Hypertension

    Dubai, UAE
    April 16-17, 2025

    13th European Congress on Nephrology, Internal Medicine and Kidney Diseases

    Paris, France

    Dysproteinemias Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in